Oxcarbazepine
You should carefully read the contents of this leaflet before using the medicine, as it contains important information for the patient.
Karbagen contains the active substance oxcarbazepine.
Karbagen belongs to a group of antiepileptic or anticonvulsant medicines used to treat epilepsy.
Karbagen helps control seizures or fits in patients with epilepsy.
In people with epilepsy, there are periods of uncontrolled electrical activity in the brain.
These periods of uncontrolled electrical activity can lead to seizures. Oxcarbazepine helps control the electrical activity of the brain. This reduces the likelihood of seizures.
Karbagen is used to treat partial seizures with or without secondary generalized tonic-clonic seizures. Partial seizures involve a limited area of the brain, but can spread to the entire brain and cause generalized tonic-clonic seizures. There are two types of partial seizures: simple and complex. In simple partial seizures, the patient remains conscious, while in complex partial seizures, the patient's consciousness is altered.
Oxcarbazepine is used in adults and children aged 6 years and older. Usually, the doctor will try to find one medicine that is most suitable for the patient (adult or child).
However, in some cases of epilepsy, it may be necessary to take two or more medicines together to control seizures.
Karbagen, coated tablets, can be used as the only medicine or in combination with other antiepileptic medicines.
You should carefully follow all the doctor's instructions, even if they differ from the information contained in this leaflet.
Before starting treatment with Karbagen, you should discuss with your doctor or pharmacist:
• if you have an allergy (hypersensitivity) to carbamazepine, a similar antiepileptic medicine.If you are allergic to carbamazepine, there is a 1 in 4 (25%) chance that you may also be allergic to oxcarbazepine.
• if you have liver problems or if they develop during treatment (see "Possible side effects").
• if you have kidney problems, especially those related to low sodium levels in the blood.Oxcarbazepine may further decrease sodium levels in the blood, which can lead to symptoms of sodium deficiency (see "Possible side effects"). In case of kidney disease, your doctor may order blood tests before starting therapy and regularly after starting treatment with Karbagen.
• if you are taking other medicines that may decrease sodium levels in the blood (e.g. diuretics, desmopressin, and non-steroidal anti-inflammatory drugs (NSAIDs) such as indomethacin and ibuprofen).See "Karbagen and other medicines".
• if you have heart disease, such as heart failure (shortness of breath and swelling of the ankles).Your doctor will regularly check your weight to see if you are retaining water.
• if you have a heart rhythm disorder
• if you are taking hormonal contraceptives (see "Karbagen and other medicines").
The risk of serious skin reactions associated with carbamazepine or its derivatives in patients of Chinese Han and Thai origin can be predicted based on blood test results.Your doctor will inform you if a blood test is necessary before starting treatment with oxcarbazepine. If you belong to other Asian ethnic groups (e.g. Filipino or Malay), your doctor may also consider the need for a blood test before starting treatment.
Your doctor may order thyroid function tests before and during treatment in children.
Tell your doctor about all the medicines you are currently taking or have recently taken, as well as any medicines you plan to take, especially if you are taking any of the following medicines that may interact with oxcarbazepine:
• other antiepileptic medicines, such as phenobarbital, phenytoin, carbamazepine, lamotrigine, and valproic acid.Your doctor may need to adjust the dosage of these medicines if you are also taking Karbagen. When taken in combination with lamotrigine, there is an increased risk of side effects such as nausea, drowsiness, pain, and dizziness.
• hormonal contraceptives ("birth control pills").Karbagen may reduce their effectiveness. You should use other methods of contraception.
• medicines used to treat mental disorders, such as lithium salts and monoamine oxidase inhibitors (MAOIs) such as phenelzine and moclobemide.Concomitant use with lithium salts may increase the risk of side effects.
• medicines that may decrease sodium levels in the blood (e.g. diuretics, desmopressin, and non-steroidal anti-inflammatory drugs (NSAIDs) such as indomethacin and ibuprofen).Oxcarbazepine may further decrease sodium levels in the blood, which can lead to symptoms of sodium deficiency (see "Possible side effects"). Your doctor should order blood tests before starting treatment and regularly after starting treatment with Karbagen.
• medicines that affect the immune system (immunosuppressants), such as cyclosporine and tacrolimus
• rifampicin (an antibiotic used to treat infections)
You should be careful when consuming alcohol while taking Karbagen, as it may cause excessive drowsiness.
If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, you should consult your doctor or pharmacist before taking this medicine.
Oxcarbazepine affects the effectiveness of hormonal contraceptives, which can lead to pregnancy.If you are of childbearing age, you should use other methods of contraception.
Controlling seizures during pregnancy is important, but taking antiepileptic medicines during this time may harm the unborn baby.
Birth defects
Studies have not shown an increased risk of birth defects associated with oxcarbazepine during pregnancy, but it cannot be completely ruled out.
Disorders of the nervous system
Some studies have shown that exposure to oxcarbazepine in the womb may negatively affect brain development (nervous system development) in children, while others have not shown such an effect.It cannot be ruled out that there may be an impact on nervous system development.
Your doctor will discuss the benefits and risks associated with taking Karbagen during pregnancy and help you decide whether to take the medicine.
You should not stop taking Karbagen during pregnancy without first consulting your doctor.
If you are taking this medicine and want to breastfeed, you should consult your doctor.The active substance of Karbagen passes into breast milk. Although available data indicate that the amount of Karbagen that passes into the baby's body is small, it cannot be ruled out that there may be a risk of side effects in the baby. Your doctor will discuss the benefits and risks associated with breastfeeding while taking Karbagen. If you are breastfeeding while taking Karbagen and notice any side effects in your baby, such as excessive drowsiness or poor weight gain, you should immediately inform your doctor.
Oxcarbazepine has a moderate effect on the ability to drive and use machines.You should remember that oxcarbazepine may cause side effects such as dizziness, drowsiness, balance and coordination disorders, vision problems, including double or blurred vision, decreased sodium levels in the blood, which can weaken muscles, decreased consciousness, especially at the beginning of treatment or when the dose is increased, which can affect the ability to drive and use machines. If you experience such side effects, you should not drive or operate machinery.
If your doctor has told you that you have an intolerance to some sugars, you should consult your doctor before taking this medicine.
You should always take this medicine exactly as your doctor has told you.If you are not sure, ask your doctor or pharmacist.
If the required dose cannot be administered using whole tablets, other preparations containing oxcarbazepine are available.
Your doctor will probably start treatment with a low dose and, if necessary, gradually increase it according to your individual needs.
The initial dose is 300 mg twice a day.If necessary, your doctor may gradually increase the dose by a maximum of 600 mg per day at weekly intervals. The maintenance dose is 600-2400 mg per day.
If you are taking other antiepileptic medicines, your doctor may reduce their dose or increase the dose of Karbagen more slowly.
If you are replacing other antiepileptic medicines with Karbagen, their doses will be gradually reduced.
The initial dose is 8-10 mg/kg body weight per day, given in two doses.If necessary, your doctor may increase the daily dose by about 10 mg/kg body weight at weekly intervals, up to a maximum dose of 46 mg/kg body weight per day. The maintenance dose of oxcarbazepine used in combination with other antiepileptic medicines is usually 30 mg/kg body weight per day.
For children who cannot swallow tablets or for whom the required dose cannot be administered using tablets, other preparations containing oxcarbazepine are available.
Karbagen is not recommended for use in children under 6 years of age, as its efficacy and safety have not been established in this age group.
In patients with renal impairment, your doctor may start treatment with half the usual initial dose and increase the dose of Karbagen more slowly than indicated above.
In patients with severe hepatic impairment, your doctor may adjust the dose.You should always follow your doctor's instructions.
If the required dose cannot be administered using whole tablets, other pharmaceutical forms of Karbagen containing oxcarbazepine are available.
The tablets should be swallowed with a glass of water, with or without food.Do not chew or crush the tablets.The dividing line on the tablet is only to facilitate breaking the tablet to make it easier to swallow, but it does not allow the tablet to be divided into two equal doses.
If you have taken more than the prescribed dose of Karbagen, you should immediately contact your doctor or pharmacist.Symptoms of overdose include low sodium levels in the blood, aggression, agitation, confusion, drowsiness or dizziness, nausea (vomiting), vomiting, fatigue, changes in heart rhythm (fast or irregular heartbeat), tremors, seizures/convulsions, headaches, itching, loss of consciousness, involuntary movements (muscle spasms or twitching), double or blurred vision, pupil constriction, low blood pressure, difficulty breathing, abnormal muscle or body activity, lack of coordination, and involuntary eye movements.
Take the missed dose as soon as you remember.If it is almost time for the next dose, do not take the missed dose and take the next dose at the scheduled time. Do not take a double dose to make up for the missed dose.
You should not suddenly stop taking Karbagen without consulting your doctor, as this may lead to a sudden increase in seizures.If treatment with Karbagen needs to be stopped, your doctor will do it gradually.
If you have any further questions about taking Karbagen, you should ask your doctor or pharmacist.
Like all medicines, Karbagen can cause side effects, although not everybody gets them.
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Common(may affect up to 1 in 10 people):
Very rare(may affect up to 1 in 10,000 people):
These side effects of Karbagen are usually mild to moderate.Most of them are temporary and usually resolve gradually.
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist.Side effects can be reported directly to the Department of Adverse Reaction Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton or blister.
Store below 30°C.
Medicines should not be disposed of via wastewater or household waste.Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Karbagen 150 mg, 300 mg, and 600 mg coated tablets is oxcarbazepine.
Each tablet contains 150 mg, 300 mg, or 600 mg of oxcarbazepine.
The other ingredients are:
tablet core:crospovidone, hypromellose, microcrystalline cellulose, colloidal anhydrous silica, and magnesium stearate
tablet coating:Opadry Buff II OY-LS-37200: titanium dioxide (E171), lactose monohydrate (see "Karbagen contains lactose"), macrogol 4000, hypromellose, yellow iron oxide (E172), red iron oxide (E172), black iron oxide (E172); Opadry White II OY-LS-28908: titanium dioxide (E171), lactose monohydrate (see "Karbagen contains lactose"), macrogol 4000, hypromellose
Coated tablet.
The tablets are oval, convex, and light yellow, with a dividing line on both sides.The dividing line facilitates breaking the tablet to make it easier to swallow, but it does not allow the tablet to be divided into two equal doses.
Karbagen 150 mg coated tablets are marked with "OX/150" on one side and "G/G" on the other side.
Karbagen 300 mg coated tablets are marked with "OX/300" on one side and "G/G" on the other side.
Karbagen 600 mg coated tablets are marked with "OX/600" on one side and "G/G" on the other side.
Karbagen is available in plastic containers of 100, 200, and 500 tablets, and in blisters of 10, 20, 30, 50, 60, 100, and 200 tablets.*
*Not all pack sizes may be marketed.
Karbagen is available as Karbagen 150 mg, 300 mg, and 600 mg coated tablets.
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
DUBLIN
Ireland
McDermott Laboratories Ltd. T/A Gerard Laboratories, 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13, Ireland
Mylan Hungary Kft., Mylan utca 1., Komárom, 2900, Hungary
Belgium: Oxcarbazepine Viatris 150 mg, 300 mg, 600 mg film-coated tablets
Denmark: Oxcarbazepin Viatris
France: Oxcarbazepine Viatris 150 mg, 300 mg, 600 mg film-coated tablets
Germany: Oxcarbazepin dura 150 mg, 300 mg, 600 mg film-coated tablets
Poland:
Karbagen
Slovenia: KARBOX 150 mg, 300 mg, 600 mg film-coated tablets
Spain: Oxcarbazepina VIATRIS 300 mg, 600 mg film-coated tablets EFG
Netherlands: Oxcarbazepine Viatris 150 mg, 300 mg, 600 mg film-coated tablets
United Kingdom (Northern Ireland): Oxcarbazepine Mylan 150 mg, 300 mg and 600 mg Film Coated Tablets
For more information about this medicine, you should contact your local representative of the marketing authorization holder:
Tel: +48 22 546 64 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.